Bausch Health Companies (BHC) Cash & Equivalents Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bausch Health Companies (BHC) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 69.13% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 56.51% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 12.49% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 78.40% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 5.67% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 65.36% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 19.14% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 120.52% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.67% |
| Mar 31, 2026 | 14.55% |
| Dec 31, 2025 | 10.84% |
| Sep 30, 2025 | 81.92% |
| Jun 30, 2025 | 190.25% |
| Mar 31, 2025 | 54.71% |
| Dec 31, 2024 | 24.71% |
| Sep 30, 2024 | -5.39% |
| Jun 30, 2024 | 2.76% |
| Mar 31, 2024 | 41.51% |
| Dec 31, 2023 | 67.91% |
| Sep 30, 2023 | 56.38% |
| Jun 30, 2023 | -12.14% |
| Mar 31, 2023 | -58.53% |
| Dec 31, 2022 | -3.09% |
| Sep 30, 2022 | -29.57% |
| Jun 30, 2022 | 2.65% |
| Mar 31, 2022 | 83.95% |
| Dec 31, 2021 | -3.80% |
| Sep 30, 2021 | -29.38% |